Complicated diverticular disease infection of diverticula
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Only left-sided uncomplicated (mild) acute diverticulitis; 2. Clinical suspicion of acute diverticulitis. For acute diagnostic work-up: ultrasound or CT proven diverticulitis. In the case of diverticulitis-negative ultrasound in clinically suspected patients an intravenous contrast-enhanced CT scan is mandatory for confirmation of diverticulitis or exclusion of other pathology. CT for Hinchey/Ambrosetti classification (which is a CT-based classification system) is needed for all patients, but can be delayed 1 day in those with ultrasound diagnosis. Staging diverticultis is defined according the modified Hinchey/Ambrosetti staging, only stages 1a and 1b and "mild" diverticulitis are included; 3. All patients with informed consent.
Exclusion criteria
Exclusion criteria: 1. Previous radiological (ultrasound and/or CT) proven episode of diverticulitis; 2. Colonic cancer; 3. Inflammatory bowel disease (ulcerative colitis, Crohn's disease); 4. Hinchey stages 2, 3 and 4 or "severe" diverticulitis according to the Ambrosetti criteria, which require surgical or percutaneous treatment; 5. Disease with expected survival of less than 6 months; 6. Contraindication for the use of the study medication (e.g. patients with advanced renal failure or allergy to antibiotics used in this study); 7. Pregnancy, breastfeeding; 8. ASA (American Society of Anaesthesiologists) classification > III; 9. Immunocompromised patients; 10. Clinical suspicion of bacteraemia (i.e. sepsis); 11. The inability of reading/understanding and filling in the questionnaires; 12. Antibiotic use in the 4 weeks before admittance.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary endpoint is time-to-recovery with a 6-month follow-up period. | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary endpoints are time to discharge from hospital, occurrence of complicated diverticulitis requiring surgery or percutaneous treatment, morbidity, health related quality of life, readmission rate, recurrence rate, medical and non-medical costs, and antibiotic resistance/sensitivity. | — |
Countries
Netherlands